Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models

被引:7
|
作者
Siripuram, Vijay K. [1 ]
Wright, Daniel F. B. [1 ]
Barclay, Murray L. [2 ,3 ]
Duffull, Stephen B. [1 ]
机构
[1] Univ Otago, Sch Pharm, Otago Pharmacometr Grp, Dunedin, New Zealand
[2] Christchurch Hosp, Dept Gastroenterol, Christchurch, New Zealand
[3] Christchurch Hosp, Dept Clin Pharmacol, Christchurch, New Zealand
关键词
Identifiability; Parameter precision; Population analysis; PKPD models; Optimal study design; NONMEM; MIXED-EFFECTS MODELS; 4 BASIC MODELS; STRUCTURAL IDENTIFIABILITY; GLOBAL IDENTIFIABILITY; COMPARTMENTAL-MODELS; PARAMETER-ESTIMATION; DESIGN; RESPONSES; SYSTEMS; INDISTINGUISHABILITY;
D O I
10.1007/s10928-017-9530-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Identifiability is an important component of pharmacokinetic-pharmacodynamic (PKPD) model development. Structural identifiability is concerned with the uniqueness of the model parameters for a set of perfect input-output data and deterministic identifiability with the precision of parameter estimation given imperfect input-output data. We introduce two subcategories of deterministic identifiability, external and internal, and consider factors that distinguish between these forms. We define external deterministic identifiability as a function of externally controllable variables, i.e., the design, and internal deterministic identifiability as a function of the model and its parameter values. The concepts are explored using three common PK and PKPD models, and verified for their precision for the selected set of parameter values under optimal design.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 50 条
  • [1] Deterministic identifiability of population pharmacokinetic and pharmacokinetic–pharmacodynamic models
    Vijay K. Siripuram
    Daniel F. B. Wright
    Murray L. Barclay
    Stephen B. Duffull
    Journal of Pharmacokinetics and Pharmacodynamics, 2017, 44 : 415 - 423
  • [2] An Approach for Identifiability of Population Pharmacokinetic-Pharmacodynamic Models
    Shivva, V.
    Korell, J.
    Tucker, I. G.
    Duffull, S. B.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2013, 2 (06):
  • [3] THE DETERMINISTIC IDENTIFIABILITY OF NONLINEAR PHARMACOKINETIC MODELS
    GODFREY, KR
    FITCH, WR
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1984, 12 (02): : 177 - 191
  • [4] A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
    Ari Brekkan
    Luis Lopez-Lazaro
    Gunnar Yngman
    Elodie L. Plan
    Chayan Acharya
    Andrew C. Hooker
    Suresh Kankanwadi
    Mats O. Karlsson
    The AAPS Journal, 20
  • [5] Population pharmacokinetic-pharmacodynamic analysis of givinostat
    Fiorentini, Francesco
    Germani, Massimiliano
    Del Bene, Francesca
    Pellizzoni, Cinzia
    Cazzaniga, Sara
    Rocchetti, Maurizio
    Bettica, Paolo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (04) : 229 - 238
  • [6] A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
    Brekkan, Ari
    Lopez-Lazaro, Luis
    Yngman, Gunnar
    Plan, Elodie L.
    Acharya, Chayan
    Hooker, Andrew C.
    Kankanwadi, Suresh
    Karlsson, Mats O.
    AAPS JOURNAL, 2018, 20 (05):
  • [7] Development of translational pharmacokinetic-pharmacodynamic models
    Mager, D. E.
    Jusko, W. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 909 - 912
  • [8] Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics
    Kreuer, S.
    Bruhn, J.
    Wilhelm, W.
    Bouillon, T.
    ANAESTHESIST, 2007, 56 (06): : 538 - 556
  • [9] AN APPLICATION OF BAYESIAN POPULATION PHARMACOKINETIC-PHARMACODYNAMIC MODELS TO DOSE RECOMMENDATION
    WAKEFIELD, J
    RACINEPOON, A
    STATISTICS IN MEDICINE, 1995, 14 (9-10) : 971 - 986
  • [10] Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients
    Mentré, F
    Pousset, F
    Comets, E
    Plaud, B
    Diquet, B
    Montalescot, G
    Ankri, A
    Mallet, A
    Lechat, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (01) : 64 - 78